Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 21Colorectal Neoplasms 8Colonic Neoplasms 6Carcinoma, Hepatocellular 6Rectal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Unspecified Adult Solid Tumor, Protocol Specific 3Pancreatic Neoplasms 3Biliary Tract Neoplasms 3Head and Neck Neoplasms 2HER2-positive Gastric Cancer 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lung Neoplasms 1Gastric Adenocarcinoma 1Fruquintinib 1For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Efficacy and Safety 1Drug-Related Side Effects and Adverse Reactions 1Cholangiocarcinoma 1

Interventions

Cisplatin 86Radiotherapy 71Paclitaxel 50Fluorouracil 38Carboplatin 36Drug Therapy 32Neoadjuvant Therapy 23toripalimab 19tislelizumab 18pembrolizumab 17camrelizumab 17Irinotecan 17Esophagectomy 17Surgical Procedures, Operative 16Radiation 16Docetaxel 16sintilimab 15Oxaliplatin 14130-nm albumin-bound paclitaxel 14nimotuzumab 11TP protocol 11S 1 (combination) 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Capecitabine 11Albumin-Bound Paclitaxel 10apatinib 9Leucovorin 9Immune Checkpoint Inhibitors 8nedaplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Esophageal Squamous Cell Carcinoma × Tegafur × Clear all
NCT06339619 2026-06-04

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
32 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06988956 2025-05-25

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
95 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06354140 2024-07-17

PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 2 Recruiting
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06187597 2024-03-12

EC-CRT-007

Sun Yat-sen University

Phase 2 Recruiting
140 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡